Press releases
CAPRISA 004 trial shows moderate protection against transmission of virus
Results of an advanced clinical trial of an antiretroviral-based microbicide candidate are being announced at the International AIDS Conference in Vienna, Austria. The CAPRISA 004 trial, which tested the safety and effectiveness of 1% tenofovir gel among nearly 900 women at two sites in South Africa, found that using the gel before and after sex provided moderate protection against sexually transmitted HIV.

your opinion
Comments are no longer being accepted.



 


last articles

search
 

newsletter